AAN 2018 Recap

The American Academy of Neurology Annual Meeting is one of the biggest events of the year. We enjoyed presenting our new tests and introducing our medical staff to attendees. Below you can find all of the presentations and information from the event, as well as links to upcoming events and webinars.



Quest offers a comprehensive array of over 700 genetic tests and related services, including advanced technologies like QNatal® Advanced and IBM™ Watson Genomics. Recent tests include:

Hearing Loss Advanced Sequencing and Copy Number Variant (CNV) Evaluation, a comprehensive and up-to-date hearing loss panel that can provide clear insight into etiology. Download brochure

ClariSure® Chromosomal Microarray Analysis (CMA) which offers the highest diagnostic yield of any single clinically available test for children with global development delay, intellectual disability, autism spectrum disroders, and multiple congenial anomalies.Learn more here.

Sat Dev Batish, PhD, FACMG

Chief Director, Genetics

Dr. Batish reviews clinical cases and provides consultations to neurologists and geneticists across the US.

Read his bio


Edward I. Ginns, MD, PhD, DABCC

Neurology Franchise Medical Director

Dr. Ginns provides medical affairs support, clinical direction and strategic oversight for neurology and neurogenetics.

Read his bio

back to top



Quest has expanded our offerings for several autoimmune neurological disorders including antibody evaluations of:

Myelin Oligodendroctye Glycoprotein (MOG)

Download the brochure to learn about diagnosing neuromyelitis optica spectrum disorder sooner.

Autoimmune Epilepsy

Download the brochure for more information about identifying the 25 specific antibodies associated with autoimmune epilepsy.

Autoimmune Encephalitis

Start treatment quicker by identifying up to 25 of the specific antibodies commonly associated with this difficult diagnosis. Download the brochure.

Stanley Naides, MD, FACP, FACR

Medical Director, Immunology

Dr. Naides is a published author of over 100 peer-reviewed papers, book chapters, and reviews with specialized interest in immunology, viral pathogenesis, autoimmunity, and infectious disease.

Read his bio

back to top


While the causes and progression of dementia are still poorly understood, the tests available are rapidly providing valuable insights for diagnosis and treatment.

Beta-Amyloid 42/40 Ratio and Apolipoprotein E (APOE) Isoform Panel, CSF

Download the brochure on this test which helps physicians better assess Alzheimer’s disease risk. We presented this poster last year and you can watch an expert webinar now on this test from Dr. Nigel Clarke.

Nigel Clarke, PhD

Medical Director, Immunology
Quest Diagnostics

back to top